Akums Drugs Partners With LC Ingredients To Market Cynatine
However, Cynatine’s high bioavailability makes it capable of delivering keratin peptides to the body and can be consumed by humans, with no fear of toxicity associated with it
Photo Credit : Shutterstock,
Akums Drugs & Pharmaceuticals Ltd., a contract manufacturing pharmaceutical company in India, has recently forged exclusive collaboration with LC Ingredients to procure the raw material, manufacture, innovate and sell finished products containing Cynatine to all Indian big pharma and nutraceutical companies.
Deficiency of the fibrous protein called keratin in hair and nails results in increase in hair loss, thin and grey hair, as well as easily breakable and discoloured fingernails. Conversely, lack of keratin in the skin makes it more prone to wrinkles, sagging, and dullness. Keratin, in its original form, is insoluble and non-absorbable by the body, hence cannot be consumed by humans. However, Cynatine’s high bioavailability makes it capable of delivering keratin peptides to the body and can be consumed by humans, with no fear of toxicity associated with it.
“In the erstwhile market, there were no healthcare supplements other than Biotin and regular hair, nail and skin (HNS) multivitamins for controlling hair fall and other related issues, but necessarily 100 percent effective. We identified this gap and when we found out about Cynatine, the only soluble source of keratin known, we connected with the innovator company LC ingredients with the aim to get exclusive rights so that we may introduce this revolutionary healthcare supplement in India,” said Sanjeev Jain, Founder, Promoter and Director, Akums Drugs & Pharmaceuticals.